Back to top
more

Synlogic, Inc. (SYBX)

(Delayed Data from NSDQ)

$2.65 USD

2.65
546,271

-0.09 (-3.28%)

Updated Jan 24, 2020 04:00 PM ET

Add to portfolio

1-Strong Buy 1        

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1
2
3
4
5
S&P
Strong Buy
Buy
Hold
Sell
Strong Sell
500
24.66%
17.94%
9.57%
5.30%
2.19%
10.75%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

F Value | F Growth | A Momentum | F VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

View All Zacks #1 Ranked Stocks

Trades from $1

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Zacks News

Zacks Equity Research

Will Synlogic Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor in Synlogic.

SYBX

Zacks Equity Research

BioMarin to Begin Early-Stage Study on Gene Therapy for PKU

BioMarin (BMRN) is set to initiate dosing in an early-stage clinical study in the first quarter to evaluate its gene therapy candidate, BMN 307, in phenylketonuria, a rare disease affecting the brain.

BMRN FIXX RUBY SYBX

Zacks Equity Research

Can The Uptrend Continue for Synlogic?

As of late, it has definitely been a great time to be an investor Synlogic

SYBX

Zacks Equity Research

Will Synlogic Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor in Synlogic.

SYBX

Zacks Equity Research

Synlogic Discontinues Development of SYNB1020, Stock Down

Synlogic (SYBX) discontinues the development of its early-stage pipeline candidate, SYNB1020, for the treatment of hyperammonemia, following disappointing study results.

ABBV RHHBY ACOR SYBX

Zacks Equity Research

Synlogic Enters Oversold Territory

Synlogic, Inc. (SYBX) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

SYBX

Zacks Equity Research

Synlogic (SYBX) Enters Cancer Collaboration with Roche

Synlogic (SYBX) announces clinical collaboration with Roche to develop its pre-clinical cancer candidate in combination with Roche's PD-L1 inhibitor, Tecentriq.

BMY RHHBY MRK SYBX

Zacks Equity Research

Will Synlogic, Inc (SYBX) Report Negative Earnings Next Week? What You Should Know

Synlogic, Inc (SYBX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SYBX

Zacks Equity Research

Why Synlogic (SYBX) Could Be a Potential Winner

Synlogic (SYBX) sees solid earnings estimate revisions and looks poised to shock the market, and yet seems overlooked by the investors.

SYBX

Zacks Equity Research

Synlogic (SYBX) Enters Oversold Territory

Synlogic, Inc. (SYBX) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock

SYBX

Zacks Equity Research

Why Synlogic (SYBX) Might Surprise This Earnings Season

Synlogic (SYBX) is seeing encouraging earnings estimate revision activity as of late and carries a favorable rank, positioning the company for a likely beat this season.

SYBX

Zacks Equity Research

Zacks.com highlights: Enterprise Financial Services, LCI Industries, Simpson Manufacturing and Synlogic

Zacks.com highlights: Enterprise Financial Services, LCI Industries, Simpson Manufacturing and Synlogic

EFSC SSD SYBX LCII

Zacks Equity Research

New Analyst Coverage Puts the Spotlight on These 4 Stocks

More analyst coverage over the last few weeks might translate into solid price appreciation for these stocks.

EFSC SSD SYBX LCII